title: Unusual treatment of Kasabach-Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycin.
abstract: Kasabach-Merritt syndrome (KMS) is a rare complication of cavernous hemangiomas characterized with anemia, thrombocytopenia, and consumption coagulopathy. This syndrome usually develops due to superficial soft tissue hemangiomas in infancy and childhood. KMS developing secondarily to hepatic hemangioma is very rare. In this report, we aimed to present the treatment of KMS developing secondarily to giant cavernous hemangioma of the liver with transarterial chemoembolization using bleomycin.
authors.affiliation: Department of Radiology, Division of Interventional Radiology, Ege University, School of Medicine, 35100, Izmir, Turkey, halilbozkaya@yahoo.com.
authors.forename: Halil
authors.initials: H
authors.lastname: Bozkaya
authors.forename: Celal
authors.initials: C
authors.lastname: Cinar
authors.forename: Ömer Vedat
authors.initials: ÖV
authors.lastname: Ünalp
authors.forename: Mustafa
authors.initials: M
authors.lastname: Parildar
authors.forename: Ismail
authors.initials: I
authors.lastname: Oran
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D001761:Bleomycin / Q000627:therapeutic use*; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D005260:Female; D006391:Hemangioma / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D059885:Kasabach-Merritt Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D008113:Liver Neoplasms / Q000150:complications* / Q000175:diagnosis; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D001761:Bleomycin